Tenecteplase: More Evidence It Should Replace Alteplase for Ischemic Stroke Treatment

Ann Emerg Med. 2023 Dec;82(6):729-731. doi: 10.1016/j.annemergmed.2023.07.016. Epub 2023 Aug 18.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Brain Ischemia* / drug therapy
  • Fibrinolytic Agents / therapeutic use
  • Humans
  • Ischemic Stroke*
  • Stroke* / drug therapy
  • Tenecteplase / therapeutic use
  • Tissue Plasminogen Activator / therapeutic use
  • Treatment Outcome

Substances

  • Tissue Plasminogen Activator
  • Tenecteplase
  • Fibrinolytic Agents